This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kornbluth, S Articles by Hanafusa, H Search for Related Content PubMed PubMed Citation Articles by Kornbluth, S Articles by Hanafusa, H

 Previous Article  |  Next Article 

Mol Cell Biol. 1986 May; 6(5): 1545-1551

Transformation of chicken embryo fibroblasts and tumor induction by the middle T antigen of polyomavirus carried in an avian retroviral vector.

ABSTRACT

The middle T antigen of polyomavirus transformed primary chicken embryo fibroblasts when expressed from a replication-competent avian retrovirus. This in vitro-constructed retrovirus, SRMT1, is a variant of Rous sarcoma virus that encodes the middle T antigen in place of v-src. Inoculation of SRMT1 into 1-week-old chickens rapidly induced hemangiomas and hemangiosarcomas. As shown with mammalian cells infected with polyomavirus, polyomavirus middle T antigen appears to be associated with p60c-src in chicken cells infected with SRMT1. When lysates of SRMT1-infected cells immunoprecipitated with either a monoclonal antibody against p60src or anti-T serum were assayed in an in vitro kinase reaction, the middle T antigen was heavily phosphorylated. To see whether an excess of p60c-src could alter the extent of phosphorylation of the middle T protein or the process of cell transformation by middle T, cells were doubly infected with SRMT1 and NY501, a virus which overexpresses p60c-src. Doubly infected chicken embryo fibroblasts transformed with the same kinetics and were morphologically indistinguishable from chicken embryo fibroblasts infected with SRMT1 alone. Phosphorylation of the middle T antigen was elevated two- to fivefold relative to cells infected only with SRMT1.

This article has been cited by other articles:

• Sausville, J., Molinolo, A. A., Cheng, X., Frampton, J., Takebe, N., Gutkind, J. S., Feldman, R. A. (2008). RCAS/SCL-TVA Animal Model Allows Targeted Delivery of Polyoma Middle T Oncogene to Vascular Endothelial Progenitors In vivo and Results in Hemangioma Development. Clin. Cancer Res. 14: 3948-3955 [Abstract] [Full Text]  
• Gottlieb, K. A., Villarreal, L. P. (2001). Natural Biology of Polyomavirus Middle T Antigen. Microbiol. Mol. Biol. Rev. 65: 288-318 [Abstract] [Full Text]  
• Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P., Vogt, P. K. (1998). The Akt kinase: Molecular determinants of oncogenicity. Proc. Natl. Acad. Sci. USA 95: 14950-14955 [Abstract] [Full Text]  
• Watanabe, H., Saitoh, K., Kameda, T., Murakami, M., Niikura, Y., Okazaki, S., Morishita, Y., Mori, S., Yokouchi, Y., Kuroiwa, A., Iba, H. (1997). Chondrocytes as a specific target of ectopic Fos expression in early development. Proc. Natl. Acad. Sci. USA 94: 3994-3999 [Abstract] [Full Text]